Smartleaf Asset Management’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.33K Hold
113
﹤0.01% 2915
2026
Q1
$1.77K Sell
113
-185
-62% -$4.01K ﹤0.01% 2991
2025
Q4
$7.89K Buy
298
+70
+31% +$1.82K ﹤0.01% 2493
2025
Q3
$5.08K Buy
+228
New +$4.7K ﹤0.01% 2373
2025
Q1
Sell
-2
Closed -$36 2913
2024
Q4
$36 Sell
2
-145
-99% -$2.83K ﹤0.01% 2907
2024
Q3
$3.11K Buy
147
+42
+40% +$939 ﹤0.01% 2324
2024
Q2
$2.11K Buy
+105
New +$2.19K ﹤0.01% 2208

Other funds holding FLGT

Smartleaf Asset Management's FLGT Position: Q2 2026 in Review

Smartleaf Asset Management held its Fulgent Genetics (FLGT) position steady in Q2 2026 at 113 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #2915.

Smartleaf Asset Management first reported a position in FLGT in Q2 2024 and has held it in 7 quarters since. The position peaked at $7.89K in Q4 2025. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Smartleaf Asset Management held 113 shares of Fulgent Genetics worth $2.33K as of Q2 2026.
  • Smartleaf Asset Management left its Fulgent Genetics share count unchanged in Q2 2026.
  • Fulgent Genetics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2915 holding.
  • Smartleaf Asset Management first reported a position in Fulgent Genetics in Q2 2024 and has held it in 7 quarters since.
  • Smartleaf Asset Management's Fulgent Genetics position peaked at $7.89K in Q4 2025.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.